サワイグループホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/05 | 4,725 | 4,785 | 4,720 | 4,760 | +15 | +0.3% | 54,100 |
2021/08/04 | 4,730 | 4,760 | 4,720 | 4,745 | +30 | +0.6% | 53,100 |
2021/08/03 | 4,720 | 4,740 | 4,695 | 4,715 | -15 | -0.3% | 41,700 |
2021/08/02 | 4,730 | 4,755 | 4,690 | 4,730 | +50 | +1.1% | 91,500 |
2021/07/30 | 4,725 | 4,740 | 4,675 | 4,680 | -75 | -1.6% | 74,800 |
2021/07/29 | 4,755 | 4,760 | 4,710 | 4,755 | ±0 | ±0% | 55,900 |
2021/07/28 | 4,745 | 4,770 | 4,740 | 4,755 | +20 | +0.4% | 55,000 |
2021/07/27 | 4,745 | 4,745 | 4,720 | 4,735 | +15 | +0.3% | 59,400 |
2021/07/26 | 4,730 | 4,735 | 4,685 | 4,720 | +20 | +0.4% | 78,400 |
2021/07/21 | 4,645 | 4,715 | 4,625 | 4,700 | +80 | +1.7% | 109,000 |
2021/07/20 | 4,630 | 4,645 | 4,600 | 4,620 | -75 | -1.6% | 111,300 |
2021/07/19 | 4,700 | 4,725 | 4,680 | 4,695 | -90 | -1.9% | 127,000 |
2021/07/16 | 4,815 | 4,815 | 4,770 | 4,785 | -30 | -0.6% | 48,200 |
2021/07/15 | 4,820 | 4,835 | 4,795 | 4,815 | +25 | +0.5% | 66,600 |
2021/07/14 | 4,700 | 4,800 | 4,700 | 4,790 | +60 | +1.3% | 83,100 |
2021/07/13 | 4,750 | 4,760 | 4,710 | 4,730 | ±0 | ±0% | 54,100 |
2021/07/12 | 4,695 | 4,735 | 4,685 | 4,730 | +90 | +1.9% | 104,100 |
2021/07/09 | 4,665 | 4,690 | 4,580 | 4,640 | -60 | -1.3% | 222,000 |
2021/07/08 | 4,800 | 4,800 | 4,700 | 4,700 | -125 | -2.6% | 191,300 |
2021/07/07 | 4,785 | 4,845 | 4,735 | 4,825 | -90 | -1.8% | 173,000 |
2021/07/06 | 4,955 | 4,975 | 4,900 | 4,915 | -35 | -0.7% | 61,400 |
2021/07/05 | 4,985 | 5,020 | 4,950 | 4,950 | -40 | -0.8% | 57,100 |
2021/07/02 | 4,965 | 5,030 | 4,960 | 4,990 | -10 | -0.2% | 112,700 |
2021/07/01 | 4,950 | 5,020 | 4,910 | 5,000 | +50 | +1% | 117,800 |
2021/06/30 | 5,070 | 5,070 | 4,950 | 4,950 | -60 | -1.2% | 108,300 |
2021/06/29 | 5,090 | 5,090 | 5,000 | 5,010 | -70 | -1.4% | 65,900 |
2021/06/28 | 5,070 | 5,100 | 5,030 | 5,080 | +30 | +0.6% | 78,500 |
2021/06/25 | 5,000 | 5,070 | 5,000 | 5,050 | +50 | +1% | 70,500 |
2021/06/24 | 4,950 | 5,040 | 4,950 | 5,000 | +15 | +0.3% | 53,600 |
2021/06/23 | 4,945 | 5,030 | 4,925 | 4,985 | +55 | +1.1% | 111,700 |
2021/06/22 | 4,950 | 4,970 | 4,895 | 4,930 | +80 | +1.6% | 66,000 |
2021/06/21 | 4,835 | 4,895 | 4,810 | 4,850 | -25 | -0.5% | 159,600 |
2021/06/18 | 4,920 | 5,020 | 4,870 | 4,875 | -45 | -0.9% | 289,900 |
2021/06/17 | 5,020 | 5,030 | 4,880 | 4,920 | -65 | -1.3% | 177,700 |
2021/06/16 | 4,970 | 5,020 | 4,960 | 4,985 | -15 | -0.3% | 91,200 |
2021/06/15 | 5,010 | 5,050 | 4,980 | 5,000 | -10 | -0.2% | 56,400 |
2021/06/14 | 5,050 | 5,050 | 4,990 | 5,010 | ±0 | ±0% | 41,600 |
2021/06/11 | 5,080 | 5,080 | 4,980 | 5,010 | -40 | -0.8% | 92,000 |
2021/06/10 | 5,040 | 5,070 | 4,990 | 5,050 | +50 | +1% | 85,800 |
2021/06/09 | 4,950 | 5,040 | 4,945 | 5,000 | +110 | +2.2% | 85,000 |
2021/06/08 | 4,900 | 4,925 | 4,860 | 4,890 | +35 | +0.7% | 53,700 |
2021/06/07 | 4,845 | 4,885 | 4,835 | 4,855 | -20 | -0.4% | 95,600 |
2021/06/04 | 4,850 | 4,880 | 4,815 | 4,875 | +30 | +0.6% | 83,600 |
2021/06/03 | 4,795 | 4,865 | 4,755 | 4,845 | +85 | +1.8% | 116,500 |
2021/06/02 | 4,720 | 4,785 | 4,715 | 4,760 | -10 | -0.2% | 148,100 |
2021/06/01 | 4,845 | 4,850 | 4,750 | 4,770 | -10 | -0.2% | 99,500 |
2021/05/31 | 4,745 | 4,865 | 4,740 | 4,780 | -35 | -0.7% | 134,300 |
2021/05/28 | 4,825 | 4,825 | 4,775 | 4,815 | +50 | +1% | 105,700 |
2021/05/27 | 4,815 | 4,845 | 4,765 | 4,765 | -40 | -0.8% | 177,500 |
2021/05/26 | 4,750 | 4,845 | 4,745 | 4,805 | -5 | -0.1% | 137,500 |
701~
750
件表示中 / 785件
類似銘柄と比較する
現在ご覧いただいている「サワイGHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サワイGHD | 572,300円 | +14.2% | +48.9% | 2.78% | 8.36倍 | 1.18倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ツムラ | 405,000円 | +22.6% | +68.1% | 3.36% | 10.79倍 | 1.14倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
ペプチド | 219,600円 | +56.7% | +357.2% | 0.00% | 20.33倍 | 7.05倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 319,000円 | +1.2% | -6.3% | 3.89% | 8.77倍 | 0.98倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
科研薬 | 376,500円 | +4.2% | -21.6% | 3.98% | 25.46倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム